GLO1 and myasthenia gravis: These studies have implicated high concentrations of MG and/or low Glo-1 activity in the etiology of metabolic disorders, such as diabetes (Wautier and Guillausseau, 2001; Ramasamy et al., 2005; Goldin et al., 2006).